Cafepharma Today

June 10 2025 - Novo Nordisk starts new CagriSema weightloss drug trial
Novo Nordisk starts new CagriSema weightloss drug trial
Vaccine stocks muted as Wall Street takes 'wait and watch' approach after Kennedy's shake-up
A medical device trade war is brewing between the EU and China
Merck antibody drug for RSV approved by FDA
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

High Profitability and Low Valuation for Gilead
Motley Fool
Monday, May 28, 2012 - 11:19am
tags:
Gilead
Dr. Reddy's Laboratories Should Continue To Gain Market Share In Lucrative Markets
Seeking Alpha
Monday, May 28, 2012 - 11:17am
tags:
Dr Reddy's, India
Have J&J's Approval Hopes Vanished?
Motley Fool
Monday, May 28, 2012 - 11:16am
tags:
JNJ, bloodthinners, Xarelto
The Meaningless Drug Approval That Could Cost the Industry Billions
Motley Fool
Monday, May 28, 2012 - 11:16am
tags:
drug approvals, Pfizer, tafamidis, familial amyloid polyneuropathy
Mylan Launches Generics for Bonviva and Viramune
Yahoo/Zacks
Monday, May 28, 2012 - 11:14am
tags:
Mylan, Bonviva, generics, Europe, UK, Roche, Boehringer Ingelheim, osteoporosis, HIV, Viramune
Human Genome Shareholders Should Not Get Greedy
Seeking Alpha
Monday, May 28, 2012 - 11:11am
tags:
GSK, M&A, Human Genome Sciences
Reports: Sanofi, Merck Bid At Least $25 Per Share For Amylin
Barron's
Monday, May 28, 2012 - 11:11am
tags:
Merck, Sanofi, Amylin, M&A
Ranbaxy brings in U.S. consultants as part of consent decree
Fierce Pharma
Friday, May 25, 2012 - 11:21am
tags:
Ranbaxy, India, generics, United States, DOJ
FDA Panel Sends Mixed Message About Pfizer Drug
Pharmalot
Friday, May 25, 2012 - 11:19am
tags:
FDA, advisory panel, Pfizer, tafamidis, familial amyloid polyneuropathy
Onyx Pharma shares rise as analyst says sales of myeloma drug could reach $1B a year by 2016
Yahoo/AP
Friday, May 25, 2012 - 11:18am
tags:
Onyx, myeloma, Kyprolis
Glaxo Diabetes Drug Data Revealed Amid Hostile Takeover
Bloomberg
Friday, May 25, 2012 - 11:16am
tags:
GSK, diabetes, M&A, albiglutide, Human Genome Sciences
Pfizer says EU advisory panel recommends approval for its advanced kidney cancer drug Inlyta
Yahoo/AP
Friday, May 25, 2012 - 11:15am
tags:
Inlyta, Pfizer, Europe, kidney cancer
Johnson & Johnson Could Slip 5% On Lower Margins
Seeking Alpha
Friday, May 25, 2012 - 10:02am
tags:
JNJ
EU body wants new guidance on Boehringer clot drug
Reuters
Friday, May 25, 2012 - 10:01am
tags:
bloodthinners, Pradaxa, Boehringer Ingelheim, Europe, EMA
U.S. Senate passes bipartisan FDA funding bill
Reuters
Friday, May 25, 2012 - 10:01am
tags:
Senate, FDA, PDUFA
Takeda chases emerging market sales with Brazil buy
Reuters
Friday, May 25, 2012 - 9:57am
tags:
Takeda, M&A, Brazil, Multilab
The Medicare Drug 'Donut Hole' is a Much Smaller Problem Than You Think
Forbes
Friday, May 25, 2012 - 9:56am
tags:
Medicare
FDA Nod for Merck Drug Label Update
Yahoo/Zacks.com
Friday, May 25, 2012 - 9:52am
tags:
Merck, Isentress, HIV, FDA
As The Senate Vote On PDUFA Finally Nears…
Pharmalot
Thursday, May 24, 2012 - 12:54pm
tags:
Senate, PDUFA, drug approvals, FDA, biosimilars
Biotechnology Stocks To Watch Ahead Of ASCO 2012: Part 1
Seeking Alpha
Thursday, May 24, 2012 - 12:53pm
tags:
ASCO, Eli Lilly, Galena Biopharma, Dendreon, Exelixis, CytRx, Array Biopharma, Ariad Pharmaceuticals

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

The Bethesda Declaration
In the Pipeline
Taurine and Aging: Is There Anything to It?
In the Pipeline
Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.